GSK - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

GSK Phase III trial of Benlysta shows improvement in SLE patients

GSK’s Benlysta is a monoclonal antibody being developed to treat lupus nephritis. Credit: GSK.